Top Markets
Coin of the day
BiVictriX Therapeutics Plc BiVictriX Therapeutics Plc

BiVictriX Therapeutics Plc

BVX
Classement en actions #40615
BiVictriX Therapeutics Plc is a United Kingdom-based biotechnology firm... BiVictriX Therapeutics Plc is a United Kingdom-based biotechnology firm dedicated to pioneering innovative treatments for cancer. The company's core technology involves its distinctive Bi-Cygni therapeutics, which are engineered to precisely identify and combat specific cancer types. Their foremost development program, BVX001, is currently being advanced to address acute myeloid leukaemia. Established in 2016 as BiVictriX Plc, the organization officially adopted its present name, BiVictriX Therapeutics Plc, in August 2021. Its corporate headquarters are located in Macclesfield, United Kingdom.
Prix de l'action
$0.13607016
Dernière synchronisation: 2024-09-10
Capitalisation boursière
$112.29K
Changement (1 jour)
22.46%
Changement (1 an)
0.00%
Pays
GB
Échange BiVictriX Therapeutics Plc (BVX)

Catégorie

Le prix BVX avec la capitalisation boursière de B
BiVictriX Therapeutics Plc BiVictriX Therapeutics Plc
BVX
$0.13607016
Capitalisation boursière de BiVictriX Therapeutics Plc(BVX)
Capitalisation boursière: $112.29K
En August 2026, BiVictriX Therapeutics Plc a une capitalisation boursière de $112.29K. Cela fait de BiVictriX Therapeutics Plc la 40615th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de BiVictriX Therapeutics Plc du 2021 au 2026
BVX par rapport au top 5 des plus populaires stocks
Prix pour BVX L’actif B La capitalisation boursière de B Résultats
BiVictriX Therapeutics Plc BiVictriX Therapeutics Plc
$6,620,661 $112.29K
$5.464T +4,865,622,912.92%
BiVictriX Therapeutics Plc BiVictriX Therapeutics Plc
$5,395,727 $112.29K
$4.453T +3,965,400,794.68%
BiVictriX Therapeutics Plc BiVictriX Therapeutics Plc
$5,053,409 $112.29K
$4.170T +3,713,826,155.43%
BiVictriX Therapeutics Plc BiVictriX Therapeutics Plc
$4,441,504 $112.29K
$3.665T +3,264,127,780.83%
BiVictriX Therapeutics Plc BiVictriX Therapeutics Plc
$3,455,913 $112.29K
$2.852T +2,539,801,968.96%